Alembic Pharmaceuticals announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Olopatadine Hydrochloride ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback